The HIV+Hepatitis Policy Institute, a non-profit organization, is very grateful for support from individuals, foundations, and corporations that invest in our mission to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions. The HIV and Hepatitis Policy Institute is a 501(c)(3) tax-exempt organization. Donations to HIV+Hep are tax-deductible to the full extent allowed by law.
If you are interested in making a donation, please contact: Carl Schmid, Executive Director, at cschmid@hivhep.org.
1602B Belmont Street NW | Washington DC 20009
Facebook posts by @HIV+Hep
The state’s lawsuit alleged certain pharmacy-benefit managers shared drug pricing and other information to gain leverage during rebate negotiations with pharmaceutical companies.
Tweets by @HIV+Hep
Speaking to @eBARnews @HIVHep’s Carl Schmid highlighted @POTUS’ FY24 proposed budget including a 10-year $9.7b #PrEP delivery prog, $15m to ↑ PrEP at commty health ctrs., & a 5-year $11b prog to combat #hepC: https://t.co/rr3t3myhLF https://t.co/Grfk7lFFRh
Ohio has sued some companies that manage drug benefits, saying the firms colluded to gain leverage during drug-rebate negotiations
https://t.co/6RSX1YNn2c via @WSJ
https://t.co/6RSX1YNn2c via @WSJ
Their child’s obesity drug was working. Then their plan refused to pay. https://t.co/dkzDvLBuDV